No abstract available.
Immunoenzyme Techniques*

No abstract available.
Fluoroimmunoassay* ; Immunoenzyme Techniques*

No abstract available.
Immunoenzyme Techniques* ; Mycobacterium tuberculosis* ; Mycobacterium*

338 subjects at the age of 17-49 were undergone EIA test. Results showed an increasing trend in Chlamydia trachomatis infection. Clinical manifestations were not detected. The incidence is highest at the age of 17-26 (14.68%), 17-36 (10.67%). In the groups of genital tract inflamation, of uterine neck, of vaginitis the incidence reaches 2.7%, 12.71% and 12.50% respectively
Chlamydia trachomatis ; Immunoenzyme Techniques ; Women

At the summer workshop of the Korean Endocrine Society held in 2016, some examples of protein experiments were discussed in the session entitled “All about working with proteins.” In contrast to what the title suggested, it was unrealistic to comprehensively discuss all protein analytical methods. Therefore, the goal was to outline protein experimental techniques that are useful in research or in bench work. In conversations with clinicians, however, I have always felt that researchers who do not engage in bench science have different demands than those who do. Protein research tools that are useful in bench science may not be very useful or effective in the diagnostic field. In this paper, I provide a general summary of the protein analytical methods that are used in basic scientific research, and describe how they can be applied in the diagnostic field.
Chromatography ; Education ; Immunoenzyme Techniques ; Methods* ; Molecular Imaging

BACKGROUND: Instead of hepatitis C virus (HCV) RNA test using RT-PCR, an enzyme immunoas-say for detection of HCV core protein as a simple, rapid method for the detection of HCV viremia has been developed recently. In this study, we investigated the usefulness of HCV core protein for the detection of HCV viremia by comparing the results of HCV RNA. METHODS: The study group included 71 patients; some of whom showed anti-HCV Ab. The HCV core protein assay was performed by enzyme immunoassay (Ortho Clinical Diagnostics, Raritan, NJ, USA). RESULTS: The concordance rate between HCV RNA and HCV core protein assay was 75%. Compared with the HCV RNA results, HCV core protein assay showed 50% sensitivity and 97% specificity. Among 17 patients whose results for HCV RNA were positive and those of HCV core protein were negative, all of them had anti-HCV Ab. CONCLUSIONS: Although the sensitivity of HCV core protein was not high in cases with anti-HCV Ab, the positive results for HCV core protein suggests the presence of HCV viremia. So, HCV core protein may be used as a simple and rapid method for detection of HCV viremia.
Hepacivirus ; Humans ; Immunoenzyme Techniques ; RNA ; Sensitivity and Specificity ; Staphylococcal Protein A ; Viremia*

BACKGROUND: The hepatitis B surface antibody (anti - HBs) level has been used as an indicator for protective immunity after vaccination. Various kinds of assay systems including EIA (Enzyme Immunoas-say) and MEIA (Microparticle enzyme immunoassay) have been used for the quantification of that antibody. Although most anti - HBs assay systems have been standardized based on the WHO reference preparations, and results of the assay systems are in good agreement for most of the serums that were examined, some discrepancies in the cases have been observed among the various assay systems. In this study, four kinds of anti - HBs assay systems were compared for relative qualitative and quantitative results based on mIU/mL unit. METHODS: Serum samples from five hundred visitors to the Health Care Center, Seoul Paik Hospital were assayed by Cobas Core Anti-HBs Quant EIA II (Roche), Enzygost Anti-HBs II (DADE Behring), AxSYM AUSAB (Abbott) and Elecsys Anti-HBs (Roche). RESULTS: The concordance rates among the 4 assay kits were 92.8% (464/500) and 75.6% (378/500) was positive (anti - HBs > or =10 mIU/mL) and 17.2% (86/500) were negative. Among 36 samples (7.2%) showing discrepant results, 23 samples (4.6%) were negative by AxSym or Behring or both and positive by Elecsys or Cobas Core or both. Most of the discrepant samples showed low-level reactive results in the range of 10 to 100 IU/L for the other assay kits, which showed positive results. Quantitative agreements between 2 assay systems gave linear correlation coefficients ranging from CONCLUSIONS: The quantification of anti - HBs can show various results according to the kind of assay kit used. Samples showing relatively low reactive results in the range of 10 to 100 mIU/mL when tested by Elecsys or Cobas Core should be especially interpreted cautiously because those same samples might be negative when tested by Behring or AxSYM.
Delivery of Health Care ; Hepatitis B* ; Hepatitis* ; Immunoenzyme Techniques ; Seoul ; Vaccination

The aim of this study was to evaluate domestic enzyme immunoassay(EIA) kit ?LG HCD 3.0?(LG) for the detection of antibody to hepatitis C virus(anti-HCV) in comparision with Axsym HCV version 3.0(Axsym), Cobas Core anti-HCV EIA(Cobas). Cobas kit shows better clear distinction between positive and negative by signal/cutoff ratio(S/C), but it also reveal relatively high false positive rate. The concordance rate of test results between LG and Axsym was 96.2%, between LG and Cobas was 95.5%, and total agreement between three EIA kit was 93.9%. LG were relative poor distinction between positive and negative results, but it could be applied clinically as a screening tool for hepatitis C in general population. The S/C of one false negative result by LG was 0.91, and false positive were less than 4.0, therefore we concluded it is necessary to confirm by immunoblotting assay when S/C were between 0.8 and 4.0.
Hepacivirus ; Hepatitis C ; Immunoblotting ; Immunoenzyme Techniques* ; Mass Screening

BACKGROUND: Generalized immune activation occurs early in the course of many infectious disease. Laboratory investigations have shown that immune activation can be quantified by the measurement of soluble immune activation products in serum. Soluble CD25, CD8, and CD4 are major immune activation products. Soluble CD8 and CD4 are indices of CD8+ T cell and CD4+T cell activity, respectively. OBJECTIVE: We estimated the concentrations of these molecules in patients with leprosy. METHODS: The study population consisted of 31 patients with tuberculoid leprosy and 71 patients with lepromatous leprosy(32 cases of M. leprae negative patients and 39 cases of M. leprae positive patients). Serum samples and clinical and laboratory data were collected form each patient and control. The levels of serum soluble CD25, CD8, and CD4 were measured by sandwich enzyme immunoassay. RESULTS: The levels of serum soluble CD25 were significantly raised in leprosy patients as compared to control and did not vary signficantly between tuberculoid and lepromatous leprosy. The soluble CD8 levels in the serum of patients with leprosy did not differ from the levels of the control. The levels of serum soluble CD4 were significantly decreased in the patients with lepromatous leprosy, but not in the patients with tuberculoid leprosy. However, there was no significant correlation between CD25, CD8, and cD4 and bacterial indices in patients with lepromatous leprosy. CONCLUSIONs: There data suggest that non-specific immune activation occurs the spectrum in leprosy, while CD4+ T cell activity is significantly decreased in patients with lepromatous leprosy.
Communicable Diseases ; Humans ; Immunoenzyme Techniques ; Leprosy* ; Leprosy, Lepromatous ; Leprosy, Tuberculoid

Possible role of chlamydia trachomatis (C. trachomatis) in non-gonococcal Urethritis and chronic prostatitis was investigated by enzyme immunoassay technique in a study of 85 cases of non-gonococcal urethritis and 23 chronic prostatitis cases. 1. C. trachomatis was detected from 21 (24.7%) of 85 non-gonococcal urethritis patients and third decade represented the highest positive rate. 2. C. trachomatis was detected from 5 cases (21.7%) of 23 chronic prostatitis patients. 3. A significantly higher positive C. trachomatis detection rate of 60. 7% was obtained from those with a profuse urethral discharge compared with those with a scanty discharge. 4. A significantly higher positive C. trachomatis detection rate of 52.3% was obtained from cases with no previous history of urethritis compared with those who had previous history of urethritis in 85 cases of non-gonococcal urethritis.
Chlamydia trachomatis* ; Chlamydia* ; Humans ; Immunoenzyme Techniques* ; Prostatitis* ; Urethritis*